cannot only be explained by physiological changes during puberty; psychosocial factors contribute to this phenomenon. [3] [4] [5] In addition to the developmental demands of this age period, new but complex therapy regimes like multiple daily injections or insulin pump therapy require self-responsible adaptation and application of the daily insulin dosages within provided algorithms. 6 In older children and adolescents, decisions relating to diabetes therapy are increasingly transferred from parents to the adolescents, who have to take on autonomy that is sometimes disproportionate to their psychological maturation. Being overburdened with this responsibility or family conflicts about autonomy can result in poor adherence to diabetes therapy. 7 Therefore, T1D can lead to psychological distress. 8 Prevalence rates of mental illness are estimated to be 13.4% to 25 .7% in adolescents without a chronic disease [9] [10] [11] [12] and might even be pronounced in adolescent patients with T1D. 8, [13] [14] [15] In particular, internalizing disorders comprising depressive and anxiety symptoms as well as eating disorders seem to be elevated. 8 In a recent study, Cooper et al 14 reported a 2.3 times higher risk for specific diagnoses such as anxiety, eating-, mood-, personality, and behavior disorders in young patients with T1D. The prevalence of depression is estimated to be 10% to 26% in T1D 13, 16, 17 vs 4.7% to 6.2% in somatically healthy children and adolescents, 18, 19 of anxiety disorders it is 9% to 19% in T1D 13, 16 vs 3.8% to 7.4% 19 and in eating disorders it is also elevated to 7% to 11.5% in T1D [20] [21] [22] vs 2.8% in the general population. However, there are also studies showing no increased rates of psychiatric diagnoses. 23, 24 Methodological differences in study design, diagnostic tools, and diagnostic criteria between the studies contribute to the differences in rates. An association of psychiatric comorbidity with deteriorated metabolic control and acute diabetes complications including ketoacidosis and severe hypoglycemia is suspected 14, [25] [26] [27] [28] [29] [30] [31] [32] but there is also some literature suggesting only a weak association. 33, 34 The mediating factors in the relationship between psychiatric comorbidity and metabolic control have not yet been completely clarified. [35] [36] [37] Hormonal changes associated with stress in the hypothalamic-pituitaryadrenal-axis, with elevated catecholamines and cortisol resulting in elevated blood glucose levels might contribute 38 but also less adherence to treatment could play an important role. 27, [39] [40] [41] [42] [43] One common way of non-adherence to diabetes treatment is "insulin-manipulation" which can be performed by: (a) intentional insulin-underdosing and omission or by (b) intentional overdosing of insulin and additional injections. In a prior analysis of this study, we found this behavior in almost a third of adolescents with diabetes (29.5%). The majority were both under-and overdosing (59.2%), some were only overdosing (18.3%), some only underdosing or omitting insulin (22.5%) (data published elsewhere). 44 A link between insulinomission and psychiatric comorbidity has been established for eating disorders. The so-called "insulin-purging" is a unique way of weight control in T1D by omitting insulin to lose weight by glucosuria and ketonaemic state, reported in many studies focusing on disordered eating behavior 20, [45] [46] [47] [48] [49] and is acknowledged in the Diagnostic and Statistical Manual of mental disorders (5th ed.) as a diabetes specific inappropriate compensatory behavior. 50 Several studies describe insulin-omission in patients without eating disorders, but the underlying reasons have not been assessed systematically. 49, 51 Furthermore, insulin-omission was found to be associated with deteriorated metabolic control, higher rates of diabetes complications and mortality. [52] [53] [54] Increasing the dose or administering additional insulin seems to be as frequent as insulin-omission, 44 Therefore, the aim of our study was to systematically assess the association between intentional insulin-manipulation and psychiatric comorbidity.
Our hypotheses were that (1) insulin-manipulation is associated with the occurrence of psychiatric disorders and (2) 
| METHODS
Out of all the 55 pediatric diabetes care centers treating adolescents with T1D in Austria, 28 were randomly selected, 21 agreed to participate and were included in our study. Inclusion criteria for patients were an age between 10 and 22 years (inclusive), T1D duration of more than 1 year, sufficient German language proficiency and absence of an additional severe somatic disease or mental retardation.
Patients were contacted by their diabetes centers and written informed consent was obtained from the adolescents and their legal representatives. Participants were asked to complete a set of questionnaires, containing basic sociodemographic and medical data.
Those returning the questionnaires were contacted by our study team. Two diagnostic interviews were performed by trained research assistants either face-to-face or via telephone to assess adherence to insulin treatment and prevalence of psychiatric comorbidity. The study was approved by the Ethics Committee of the Medical University of Vienna.
| Medical data
Medical data including age, HbA1c, and diabetes duration were caused by the mental health problem had to be rated by the interviewer on a four-point Likert-scale. Impairment had to be rated at least with a code of 2 (=severe) in order to be interpreted as clinically relevant. The evaluation was dependent on the individual diagnosis and followed the rules of DSM-IV. 11 A subclinical psychiatric diagnosis was assigned when patients showed significant disabling symptoms of a specific mental health problem with clinical relevance, but did not meet all the corresponding DSM-IV criteria (eg, all but one symptom).
Both point and life-time prevalence of psychiatric disorders were assessed.
| Statistical analysis
Age differences between groups were compared using Kruskal-Wallis test. Chi-squared test was used to test for gender differences in clinical characteristics. Bonferroni-Correction was performed for multiple comparisons in prespecified hypotheses. P-values in Tables 1 and 2 were not adjusted for multiple comparisons and should be interpreted 
| Association of insulin-manipulation and psychiatric comorbidity
We explored the distribution of psychiatric disorders among the three adherence groups and found a significant increase of psychiatric comorbidity with the level of non-adherence, ranging between 17.5% and 46.5% (Figure 1 ). In patients with psychiatric comorbidity, we found 33 (64.7%) to be manipulating their insulin, while in patients without psychiatric disorders 38 (30.9%) patients showed manipulation (P = 0.001). 
| Specific psychiatric diagnoses
We found elevated rates of specific phobia, social phobia, depression, and eating disorders in the Manipulating-Group. For all other diagnoses, no significant differences were found between adherence groups (Table 1) . Both under-and overdosing were performed in the majority of the diagnoses (Table 3 ).
| Gender effect
In the female sample, the percentage of psychiatric comorbidity significantly increased with the level of non-adherence (P = 0.001), while in male patients this effect was not significant (P = 0.096) (Figure 2 ).
| Association with metabolic control
The participants of the study showed a mean HbA1c of 8.13% Generalized anxiety disorder
Abbreviations: ADHD, attention deficit/hyperactivity disorder, OCD, obsessive-compulsive disorder, EDNOS, eating disorders not otherwise specified, PTSD, posttraumatic stress disorder.
23,4%
33,3% Rates of psychiatric comorbidity -gender effect were highest in the Manipulating-Group. Patients with psychiatric comorbidity had more hospital admissions with DKA than patients without. There was no significant gender effect on DKA (P = 0.485),
severe hypoglycemia (P = 0.0568) or frequency of outpatient visits (P = 0.713) ( Table 2 ).
| DISCUSSION
In our interview based cross sectional study, we interviewed 241 young patients with T1D performing two diagnostic interviews to assess psychiatric comorbidity and adherence to insulin therapy. We found a strong association of insulin-manipulation and internalizing psychiatric comorbidity, especially in female patients. To our knowledge, this is the first study using a systematic approach to assess the prevalence of psychiatric disorders in patients who intentionally do or do not manipulate their insulin dosage.
| Rates of psychiatric comorbidity
Elevated rates of psychiatric comorbidities in patients with diabetes were detected in several studies. 8, [13] [14] [15] We found a prevalence of 29.3% and therefore, a comparable rate with Butwicka et al 63 who
found a prevalence rate of 26.6% in youth with T1D. The lower rate of psychiatric comorbidity in the Adherent-Group (17.5%) was comparable with the rates in children and adolescents without a chronic disease. 10 The increased rate up to 46.5% in the Manipulating-Group indicates that insulin-manipulation might be a risk factor for or a symptom of psychiatric disorders.
Internalizing disorders are suspected to be pronounced among young patients with T1D. 8,14 Accordingly, we found internalizing disorders elevated-but only in association with insulin-manipulation. In these patients the depression rates were four times higher, the rate of specific phobia three times higher and the rate of social phobia doubled compared to patients who were adherent to insulin therapy. The latter even had prevalence rates below the general rates. In eating disorders, we also found elevated rates associated with insulin-manipulation-which is already known from numerous previous studies. [20] [21] [22] What our study adds is that for the first time we could reveal that patients with T1D and eating disorders not only with underdose insulin for weight control purposes-but also overdose it to enable uncontrolled eating and binge eating. Interestingly, we did not find under-or overdosing associated to specific psychiatric disorders. Both behaviors were found in the majority of the diagnoses and almost two thirds of the patients performed both underdosing and overdosing of insulin.
| Gender aspects
We found female patients to be at higher risk for both psychiatric disorders and insulin-manipulation. This result corresponds to many epidemiological studies finding internalizing psychiatric disorders to be pronounced in female gender 10, 64 and therefore might reflect a general pattern in psychiatry.
| Insulin-manipulation as a symptom of internalizing psychiatric comorbidity?
So far, an association between insulin-manipulation and psychiatric disorders was only established for "insulin-purging." 50 Patients in our study reported to skip insulin because of weight loss intentions, but also because of denial of diabetes, to hide diabetes from peers, or because of self-destructive behavior or fear of hypoglycemia. Additional insulin was given to enable uncontrolled binge eating, because of self-destructive behavior or because of suicidal intentions. 44 This is in line with known symptoms of anxiety and depression: Reduced energy, lacking self-care and being self-destructive, even suicidal, by using less insulin, or by applying hazardous extra doses of insulin would be a diabetes specific symptom in depressive disorders. In anxiety disorders avoiding insulin by skipping or reducing insulin could be classified as an avoidance behavior in fear of hypoglycemia or in social phobia, when diabetes is hidden from the peers. Therefore, insulinmanipulation could be a diabetes specific symptom also in anxiety and depression.
| Association with metabolic control and diabetes complications
The strong association of insulin-manipulation with metabolic control and diabetes complications in our study underlines the role of behavior and adherence problems as mediating factors in metabolic deterioration and diabetes complications. interviews. They showed rates of depression and eating disorders far below the general prevalence rates, confirming this problem of underdiagnosing. 32, 65 Diagnostic interviews are regarded to be the most accurate way to diagnose internalizing disorders. 37 The strength of our study is the systematic approach and the use of standardized diagnostic interviews to establish psychiatric comorbidity and therapy adherence.
One limitation of our study is that out of 715 contacted patients 393 refused to participate. The refusing patients were more often males, were older, and had a higher HbA1c. One can hypothesize that these patients are the less adherent. If so, however, our study might even underestimate the rate of non-adherence with insulin therapy, probably in male patients. Furthermore, data on insulin administration is based on self-reports from the adolescent patients. There is no way to assess the actual applied amount of insulin. Electronic pump records document boluses, but some of the patients in the Manipulating-Group reported to disconnect the pump before giving a bolus or to use the "catheter priming program" for secret boluses, so those records are not always valid. 55 As patients knew their answers were treated strictly confidential, we are confident that most patients reported truthfully. Still, we might have missed some patients who manipulate insulin but were not willing to share their secret behavior, or reported to have unintentionally taken the incorrect dose which would have led to a misclassification to the Error-Group. Therefore, this group might be biased by some patients manipulating insulin. This is supported by the linear increase in diabetes complications according to level of non-adherence in the group comparisons. A further limitation refers to the low number of cases for each of the psychiatric disorders and for diabetes complications in the different groups. Results should be regarded as exploratory, however, a tendency for increasing prevalence of internalizing psychiatric disorders with the level of nonadherence can be shown.
| Implications
Diabetes teams should be aware of this secret behavior and prompt a systematic evaluation of patients with either insulin-manipulation, psychiatric symptoms or deteriorated metabolic control. Most psychiatric problems start at young age and tend to persist into adulthood. 12, 66 So, early detection of psychiatric comorbidity and insulin-manipulation is essential and may be of long-term value.
Studies assessing the persistence and diabetes outcome of insulinmanipulation and underlying psychiatric comorbidities should be performed to lay grounds for the development and evaluation of specific therapeutic interventions. We emphasize our special thanks to our colleagues of the participating diabetes care centers in Austria for their contribution to our study!
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